| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ac338118f2124f32457e333b30555df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c85119ae0918749e9d1f85c5c335b63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d1d41cd7bf39f6c95c157eac59eee36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ae0eb9f68e08c1560c97444c791a852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d87e3b154d508bf21cec514c26d29d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc35070bc1ee03fc51b66b7d2d561779
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47e6d64f3ca7f88ca5541672f0e21dca |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 |
| filingDate |
2009-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79c768ea000010fe7ded17e7be3d3ed1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7301201833e9694a512d738eeb38d729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dabdb0b29e9989948912dd83c8dba5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32f099d5037d0b46df445d9c8c95ac35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b2b7171fe8b24ec67356efb77873495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f41e21c92b1e5e1e7b25fbdbe2ff5620 |
| publicationDate |
2010-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010006306-A1 |
| titleOfInvention |
Method of treating blepharitis |
| abstract |
The present invention relates to a method for treating non-infectious, inflammatory chronic posterior blepharitis in a subject. The present invention also relates to a method for treating chronic posterior blepharitis in a subject for over two weeks. The method comprises identifying a subject in need thereof, and topically administering to the eye of the subject a pharmaceutical formulation consisting essentially of an effective amount azithromycin. The present invention further relates to a method for treating dry eye secondary to blepharitis in a subject. The method comprises the steps of: identifying a subject suffering from dry eye secondary to posterior blepharitis, and topically administering to the eye of the subject a pharmaceutical formulation comprising an effective amount of azithromycin. The present invention further relates to method for reducing contact lens intolerance of a subject due to blepharitis or dry eye secondary to blepharitis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2393355-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2862439-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2393355-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104045674-A |
| priorityDate |
2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |